Applied DNA Sciences, Inc. and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s SigNature molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules for offering to ACG’s customers to enhance product traceability and authentication. The MoU is expected to be followed by a definitive agreement.
Author: heather
APDN takes another step into pharma with traceability alliance
Supply chain security firm Applied DNA Sciences has signed a memorandum of understanding with pharmaceutical capsule and tablet manufacturer ACG for enhanced traceability and authentication of ACG’s capsule products.
The MoU, which is expected to be followed by a definitive agreement, will see Bengaluru-based ACG use APDN’s SigNature molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules to improve the product’s traceability for ACG’s pharma and nutraceutical customers.
For James Hayward, Building Companies is in The DNA
WARREN STRUGATCH
One of Long Island’s leading life-sciences entrepreneurs, James Hayward co-founded Europe’s first liposome company, Biocompatibles Ltd. in the early ’80s; headed worldwide research at Esteé Lauder from 1984 through 1989; then founded The Collaborative Group, a cluster of interconnected companies servicing the biotech, pharmaceutical, and consumer-product industries from 1990 through July 2004.
Applied DNA & ACG Sign Agreement
ACG will use Applied DNA’s SigNature molecular tagging & authentication technologies to develop empty hard-shell capsules
Applied DNA Sciences and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s SigNature® molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules.
How Scientists Are Using DNA Barcodes to Bust Counterfeiters
From high-end guitars to bolts that keep the wings attached to military aircraft, manufacturers are turning toward DNA to catch counterfeit products. A look inside the technology that’s sending crooks to jail in ways Sherlock Holmes only dreamed of.
Josh Davis dreamed of touring the United States with his rock band. He never dreamed the FBI would be in the audience.
Through the mid-2000s, the Josh Davis Band played Tucson, Arizona and Sioux Falls, South Dakota; Reno, Nevada and Little Rock, Arkansas; Dallas, Texas and Cheyenne, Wyoming; Bozeman, Montana and Tallahassee, Florida. The band earned extra cash selling guitars to pawn shops, hawking brands such as Gibson, Guild, and Martin. They sold each instrument for about $400 and used the cash to pay for gas, hotels, and food.
None of the guitars were authentic.
Dr. James Watson visits Applied DNA
“Imagine, an American company whose fundamental selling premise is the honesty of DNA tags. The honest world needs Applied DNA…and must help ensure its success.”
Dr. James Watson
Nobel Laureate, co-discoverer of DNA Structure
“Shaking THE James Watson’s hand was truly exciting for me! Watson, Crick, and Franklin were true pioneers. They interpreted the evidence and then proved to the world that what they believed to be true, was indeed. That kind of gusto is amazingly rare and inspiring. How many people alive today can say they created whole new branches of science and industry? Awesome!”
Deirdre Killebrew, Ph.D.
Associate Director, Molecular Biology
“Meeting an influential scientist such as James Watson sparks the aspiring scientist in us all. When you hear names such as Einstein, Darwin, and Tesla you feel that all the important discoveries have already occurred. He reminds us that with persistence and hard-work, great discovery may be just around the corner.”
Daniel Petrie, Jr.
Project Manager, Government and Military Programs
“It was an honor to meet the pioneer in the field of DNA whose work allows us to do what we do every day!”
Ila Lansky, Ph.D.
Director of Forensics
“To meet the scientific pioneer upon whose shoulders we stand was an honor.
To have the opportunity to tell him what we do was incredible.
To speak with him about our forward vision will drive us to great heights.”
Janice Meraglia
Vice President, Government and Military Programs
“Despite being key to one of the most significant scientific discoveries in the past century, Dr. Watson didn’t strike me as the stereotypical scientist. As he’s mentioned in his book The Double Helix, discovery can be a messy business that doesn’t follow a predetermined plan. In his visit to our company he asked us many questions that had nothing to do specifically with science, but more with the evolving needs of the world and how we were evolving and adapting our business to meet those needs. His philosophy regarding a constantly changing environment, adaptation, and natural selection seemed to transcend science and apply also to the evolution of business and human society as well. His scientific achievement is obviously impressive, but his broader wisdom and humor actually impressed me more.”
Tom Ackerman
Director of IT Business Solutions
SigNature® DNA Evidence Puts Father and Son Team Behind Bars
Authentication Results Delivered and Suspects Convicted in Record Time
STONY BROOK, N.Y. February 2, 2018. Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA” ), is pleased to report that SigNature DNA evidence has resulted in two new convictions, bringing the company’s total to 117.
Shaun Howard and his son Charlie Howard both pleaded guilty at Woolwich Crown Court (London, United Kingdom) in January 2018 and were convicted and sentenced to a total of 8 years imprisonment.
The father-son team committed a cash-in-transit attack against Loomis UK Limited on December 28, 2017, where they took possession of a cash box containing approximately £10,000 (USD equivalent $14,000). The criminals escaped in a van belonging to Shaun Howard.
They did not realize that the box also contained a security ink inoculated with SigNature DNA. Thanks to quick detective work and Automatic Number Plate Recognition (ANPR) technology, police were able to track the van and arrest the suspects.
Detectives collected evidential samples of ink stains from the suspects, which were analyzed by Applied DNA’s forensic laboratories. Within 5 working days, Kent Police received an Expert Witness report from Applied DNA that forensically linked the samples to the robbery. Nearly all of the stolen cash was recovered.
“The evidence Applied DNA has provided was invaluable and obviously assisted with the defendants entering early guilty pleas, saving time and money,” commented Detective Constable David Bull from Kent Police Serious Crime Directorate.
Tony Benson, Managing Director EMEA, added “This is the quickest conviction I have ever heard of using our SigNature DNA evidence. The number of days elapsed from the date of robbery to the criminals being sentenced was only 29, and let’s not forget Christmas and New Year holidays fell within this timeframe. This outcome is the result of excellent teamwork by police, Loomis and our forensic experts.”
This news comes hot on the heels of another conviction issued in late 2017. Clement O’Doherty was charged with handling stolen cash containing SigNature DNA, and was subsequently sentenced to 18 months for his role in a Loomis robbery at a London Tesco store in February 2017. On the same day, Mr. O’Doherty was given an additional 8 year sentence for grievous bodily harm inflicted in an unrelated case.
SigNature DNA evidence has helped to convict 117 criminals to date, with total sentences of over 550 years and many more cases in the pipeline.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
INVESTOR CONTACT: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
MEDIA CONTACT: Cheryl Schneider, Dian Griesel Int’l, 212-825-3210, cschneider@dgicomm.com
PROGRAM CONTACT: Tony Benson, Managing Director, Applied DNA Europe, +1 44 (0) 7552 429341, tony.benson@adnas.com
Applied DNA Receives First International Order for DNA Transfer System for Cotton
SigNature T DNA Transfer System Adds New Season Distinct from US Seasonality and Expands Capacity in New Markets
STONY BROOK, N.Y., (January 31, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that in response to an order from an international cotton gin, the Company will be installing its patent-pending SigNature® T DNA Transfer System at an off-shore gin. Recently, the Company has been fielding inquiries for DNA tagging of cotton from multiple foreign countries. For strategic reasons, the Company has decided not to reveal the customer and the location at this time. The SigNature T tagging system will be installed at the international gin this quarter in advance of orders for the Company’s molecular taggants.
The benefit of the SigNature T DNA Transfer System is that it can be installed within the gin’s normal processes. The system provides over 60 data points per minute to the Company’s CertainT® IT platform to monitor, record and audit the quantity of tagged bales and the quality of tagged bales associated with each USDA (or other) bale identification number. The partners in the network use the data to manage tagged bale inventory, bale shipments and lab test results for samples.
Evidence obtained from quantitative Polymerase Chain Reaction (qPCR) tests to date indicate that essentially every fiber that passes through the gin while the DNA Transfer System is operating is exposed to SigNature T DNA. Quantitative PCR, used for the Company’s SigNature® T, and our fiberTyping® and GeoTyping™ platforms allow the forensic detection of dilution of the original fibers at any point in the supply chain. The Company’s SigNify qPCR system enables testing on-site by trained, certified personnel.
“Verified cotton based on forensic science helps to establish provenance with certainty. The growers and ginners benefit directly by knowing that the cotton that is tagged, tested and tracked ends up in the finished goods that are sold in their home country. They can depend on a sustainable livelihood knowing that the brands and retailers behind the program are their champions, enabling for continuous planting of cotton, ginning and production for future generations,” said MeiLin Wan, Applied DNA VP, Textiles. “You don’t get to true sustainability without traceability on the fiber itself. We are seeing a shift from reliance on a paper trail that documents unverified fiber, to a new standard based on transparency from the fiber forward, linking all parts of the value chain with our information-rich molecular traceability system.
”The SigNature T system and supply chain protocols are designed to assure the purity and integrity of any cotton whose global source of origin leads to unique performance or claims. Countries with large cotton economies often want to market finished goods based on the use of cotton exclusively from the country. In the markets of the US, Egypt, Turkey, Peru, China, Australia and India, preference is often given to cotton grown in the home country. The maintenance of intact supply chains, with forensic proof of origin can lead to substantiation of ancillary claims such as sustainable sourcing or the exclusion of cotton fibers that may have been obtained with labor derived from human trafficking.
SigNature T preserves the integrity and purity of cotton fiber from source to shelf by enabling end-to-end traceability with forensic evidence. Over 100 million data points are being captured per season from the gins into the CertainT Textile Portal and over 3,000 SigNature T tests have been conducted since 2015. Testing will increase consequent to the establishment of our lab in India. The gin data and reports are shared with the Company’s partners and customers, via the CertainT systems platform, configurable for third-party systems such as Enterprise Resource Planning or blockchain networks.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our history of losses, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Contacts: investor contact: Sanjay M. Hurry, 212-838-3777, shurry@lhai.com
media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
ADNAS contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
web: www.adnas.com, twitter: @APDN
Applied DNA Schedules Fiscal 2018 First Quarter Financial Results Conference Call for Thursday, February 8, 2018 at 4:30 PM ET
STONY BROOK, N.Y., January 30, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 first quarter ended December 31, 2017 after market close on Thursday, February 8, 2018. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern Time that will also be broadcast live over the internet.
What: Applied DNA’s Fiscal 2018 First Quarter Financial Results Conference Call
When: Thursday, February 8, 2018, at 4:30 p.m. Eastern Time
Where: Via phone by dialing +1 844-887-9402 or +1 412-317-6798 and ask for the Applied DNA call; via webcast.
A telephonic replay of the conference call will be available for one day and may be accessed by calling +1 877-344-7529 or +1 412-317-0088 with the passcode 10115974. The webcast will be archived in the Investors section of the company’s website.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics. The Company makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
The proprietary DNA-based CertainT® platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
Web: www.adnas.com | twitter: @APDN
